№ files_lp_3_process_9_64522
Regulatory and health technology assessment submission outlining the request to list a new 28-tablet pack size of rabeprazole 20 mg (Pariet®) on the Australian PBS/RPBS, including pricing justification, utilisation projections, legislative considerations, and estimated budget impact for 2022–2027.
Year: 2020
Country: Australia
Medicine: Rabeprazole sodium 20 mg enteric coated tablets
Brand: Pariet®
Sponsor: Janssen-Cilag Pty Ltd
Regulatory register: Australian Register of Therapeutic Goods (ARTG)
ARTG registration date: 22 June 2020
Type of submission: General Schedule Authority Required (STREAMLINED) PBS/RPBS listing request
Committee: Pharmaceutical Benefits Advisory Committee (PBAC)
Legislation referenced: National Health Act 1953 (section 85D)
Existing listing comparison: Rabeprazole 20 mg 30-tablet pack
Requested maximum quantity: 28 tablets
Proposed repeats: Up to 5 repeats depending on item code
Approved ex-manufacturer price proposed: $2.83
Adjusted proportional AEMP: $2.64
Indications: Gastro-oesophageal reflux disease (GORD); prevention of relapse of GORD; symptomatic treatment of GORD; active duodenal ulcer; gastric ulcer
Target population: Adult patients requiring short-term treatment (4–8 weeks)
Financial impact period: 2022–2027
Estimated net financial impact: $0 to < $10 million over six years
Hearing: No sponsor hearing conducted
Consumer comments: None received
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.